Renal Cancer
Managing the Overlapping Toxicities of Cabozantinib plus Nivolumab, a New Standard of Care in Kidney Cancer - Beyond the Abstract
February 28, 2022
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial - Beyond the Abstract
January 28, 2022
Pancreatic Metastases in Advanced Renal Cell Carcinoma: An Evolving Prognostic Paradox - Beyond the Abstract
September 23, 2021
TRIM63 Is a Sensitive and Specific Biomarker for MiT Family Aberration-Associated Renal Cell Carcinoma - Beyond the Abstract
August 5, 2021
PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer - Beyond the Abstract
July 28, 2021